MSB looks cheap, page-9

My thoughts exactly, going through their website ... sounds like Mesoblast would definitely fit into their strategy

https://www.astrazeneca.com/our-focus-areas.html

The path to new treatments

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Cardiovascular and Metabolic Diseases; Oncology; Respiratory, Inflammation and Autoimmunity; Infection and Neuroscience.

https://www.astrazeneca.com/what-science-can-do/cardiac-regeneration.html

Researchers at AstraZeneca are taking a focused approach to the growing challenge of heart failure. There are currently very few options to address the severe and progressive nature of heart failure, where the heart’s capacity deteriorates over time. The aim of AstraZeneca’s research in the area is to help a damaged heart repair itself, which sounds like science fiction but may be closer to reality than previously thought. Recent advances have demonstrated the presence of progenitor cells in the heart, which may play a role in cardiac repair.
In addition, it has been proven that adult cardiomyocytes are capable of proliferating. The stage is set for a changing treatment paradigm, and AstraZeneca is building on the latest scientific breakthroughs and technology to help heart failure patients. With the single goal in mind to help heart failure patients, we apply an integrated approach where the internal team works side-by-side with other world-leading scientists to find the best way forward.